002747SZSE

2025 Annual Independent Director's Performance Report (Chen Heng)

Estun Automation Co., Ltd.··7 pages

✨ AI Summary

This report details Independent Director Chen Heng's performance in 2025. He fulfilled his duties by attending board and shareholder meetings, reviewing financial reports, and overseeing internal controls. Chen Heng confirmed his independence and compliance with regulations, ensuring the protection of company and shareholder interests.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

2025 Annual Independent Director's Performance Report

Nanjing Estun Automation Co., Ltd. (Independent Director: Chen Heng)

As an independent director of Nanjing Estun Automation Co., Ltd. (hereinafter referred to as the "Company") during my tenure in 2025, I strictly followed the requirements of the "Company Law," "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Normative Operation of Main Board Listed Companies," the "Articles of Association," and the "Independent Director System." I diligently performed my duties, attended board and shareholder meetings, thoroughly reviewed meeting agendas, and provided opinions on relevant matters, safeguarding the interests of the Company and all shareholders. The work report for my tenure as an independent director in 2025 is as follows:

I. Basic Information of Independent Director

  1. Work Experience, Professional Background, and Concurrent Positions of Independent Director

I, Chen Heng, born in 1973, am a Chinese national with no overseas residency. I am a certified public accountant and senior accountant in China, holding a Master of Business Administration (MBA) degree. My previous positions include Senior Manager at Lixin Certified Public Accountants (Special General Partnership), Financial Controller at Shanghai Zhicheng Pipe Network Engineering Technology Co., Ltd., and Department Head of Audit Business at Zhonghua Certified Public Accountants (Special General Partnership). I have also served as Financial Controller and Investment Director at Shanghai HUGONG High-Frequency Equipment Manufacturing Co., Ltd. Currently, I am a Director, Financial Controller, and Deputy General Manager at Shanghai Kaikai Industrial Co., Ltd., Legal Representative and Executive Director of Shanghai Qiangshang Industrial Co., Ltd., Director of Shanghai Kaikai Department Store Co., Ltd., Director of China Leiyunshang Guoyao (Hong Kong) Co., Ltd., and Director of Shanghai Leiyunshang Pharmaceutical West District Co., Ltd. I have served as an independent director of the Company from July 2023 to June 2025.

  1. Independence Statement

During my tenure as an independent director of the Company, I have not directly held any shares of the Company. I have no relationship with shareholders holding more than 5% of the Company's shares, the actual controller, or other directors, supervisors, and senior management personnel of the Company. I have not held any positions in the Company other than independent director, nor have I held any positions in the main shareholder's companies. There are no circumstances that affect my independence as an independent director. This complies with the requirements regarding the independence of independent directors stipulated in the "Management Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guidelines No. 1 - Normative Operation of Main Board Listed Companies," and other relevant laws, regulations, normative documents, and the "Articles of Association" and "Independent Director System" of the Company.

II. Overview of Independent Director's Performance in the Reporting Year

  1. Attendance at Board and Shareholder Meetings

In 2025, during my tenure, the Company held 3 board meetings and 2 shareholder meetings. The convening and procedures of these meetings complied with legal requirements, and major operational decisions and other significant matters were handled in accordance with relevant procedures. During the year, I attended 3 board meetings either in person or via communication. I thoroughly reviewed all proposals submitted to the board and voted in favor of all of them, with no opposing or abstaining votes.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.